Invention Grant
- Patent Title: Angiopoietin-based interventions for treating cerebral malaria
- Patent Title (中): 促血液生成素治疗脑疟疾的干预措施
-
Application No.: US14529677Application Date: 2014-10-31
-
Publication No.: US09592271B2Publication Date: 2017-03-14
- Inventor: Lisa Arleen Purcell Ngambo , Sarah J. Higgins , Kevin C. Kain
- Applicant: Regeneron Pharmaceuticals, Inc. , University Health Network
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Alston & Bird LLP
- Agent Aparna G. Patankar
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K38/17 ; A61K38/18 ; A61K39/395 ; C07K16/22 ; A61K45/06 ; A61K31/357 ; A61K31/365 ; A61K31/49 ; C07K14/515 ; A61K39/00
Abstract:
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
Public/Granted literature
- US20160045566A1 ANGIOPOIETIN-BASED INTERVENTIONS FOR TREATING CEREBRAL MALARIA Public/Granted day:2016-02-18
Information query
IPC分类:
